News

Coronavirus Vaccine India, COVAXIN: India’s First COVID-19 Vaccine Candidate Set For Phase I, II Human Trials

Coronavirus Vaccine India, COVAXIN: India’s First COVID-19 Vaccine Candidate Set For Phase I, II Human Trials

COVAXIN, India's first COVID-19 vaccine candidate, was developed in association with ICMR

Drug manufacturers around the world are racing to develop a vaccine against the novel coronavirus; a novel virus is one that has never previously been identified in humans, making the task of creating a vaccine that much harder.

China's military has been given permission to use a vaccine candidate developed in association with CanSino Biologics.

According to Reuters the drug showed some promise in early clinical trials.

The Ad5-nCoV is one of the eight vaccine candidates developed by Chinese firms to move into human trials.

Source: www.ndtv.com
Please Help Us Keep this Site Running

Thank you for the donation

 
 
 
Powered by Stripe
Subscribe to our Newsletter

Latest News, Photos & Videos